Day: December 25, 2020
– No Damage or Operational Impact to Ole Red Nashville, Ryman Auditorium; Minor Damage Reported at Wildhorse Saloon –NASHVILLE, Tenn., Dec. 25, 2020 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) shared the following statement from its Chairman and Chief Executive Officer, Colin Reed, related to the Dec. 25, 2020 explosion on Second Avenue in downtown Nashville:“I want to express our deep concern for the individuals and business owners who have been impacted by the early morning explosion in downtown Nashville. We are thankful that, as of now, no major injuries have been reported. An initial assessment of our downtown properties revealed no damage at the Ryman Auditorium and Ole Red Nashville and minor damage to the Wildhorse Saloon. We do not anticipate any long-term business interruptions due to...
Planet Media SA :
Written by Customer Service on . Posted in Public Companies.
Planet Media (FR0010211037 – ALPLA), annonce ce jour un jugement défavorable dans le litige qui l’oppose aux cédants d’Addict Media1.Par décision du Tribunal de Commerce de Paris, rendue le 18 décembre 2020, il est ordonné à Planet Media de racheter 226.808 de ses propres actions au prix unitaire de 6,615€ auprès des cédants d’Addict Media avec exécution provisoire. La société a déjà fait appel de cette décision sur le fond et va assigner en arrêt de l’exécution provisoire.Planet Media rappelle ici que :ce litige avait été mentionné dans les risques du rapport de gestion et qu’au regard des avis fournis par les différents experts, aucune provision n’avait été jugée utile lors de la clôture des comptes annuels clos au 31 décembre 2019 et publiés en juillet 2020 ;ce risque a été revu à l’occasion de la clôture des résultats semestriels...
Monument Announces Closing of the Joint Venture Arrangement for the Tuckanarra Project in Western Australia
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Dec. 24, 2020 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” is pleased to announce that the Transaction of the Joint Venture Arrangement with Odyssey Gold Ltd (ASX: ODY) has closed, ODY now owns 80% of the Tuckanarra Gold Project (“Tuckanarra”) leaving Monument with a 20% free carry interest.Tuckanarra is located in the Murchison Goldfield. The JV arrangement allows Tuckanarra exploration to be advanced right away; and provides Monument the opportunity to have future ore produced by ODY to be fed into the Burnakura gold processing plant.At closing, Monument has received the first payment of AUD$2,000,000, leaving AUD$2,000,000 cash payable due within 6 months. A AUD$1,000,000 contingency cash payment may become payable within 36 months of completion...
FDA Provides Guidance for Adding an Open-Label Extension to CytoDyn’s Phase 3 Trial for Severe-to-Critical COVID-19 Patients Until Trial Data is Unblinded
Written by Customer Service on . Posted in Public Companies.
The agency will also consider eINDs for patients in other hospitals who qualify for inclusion criteria similar to CD12The CD12 trial completed enrollment with 394 patients on December 16VANCOUVER, Washington, Dec. 24, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the U.S. Food and Drug Administration (“FDA”) provided guidance to the Company to add an open-label extension to its Phase 3 trial (“CD12”) and specific criteria for the continuation of eINDs for patients meeting the inclusion/exclusion criteria of CD12.The CD12 protocol will be amended for adding the open-label arm extension and submitted to the FDA on Monday,...
MedMira Reports First Quarter Results FY2021
Written by Customer Service on . Posted in Public Companies.
HALIFAX, Nova Scotia, Dec. 24, 2020 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2020.Profit and Loss HighlightsRevenue: The Company recorded revenues in Q1 FY2021 of $1,602,823 compared to $89,132 in Q1 FY2020. The increase in revenue was due to the Company’s revenues generated from sales of the REVEALCOVID-19TM Total Antibody Test and associated products and services.Gross Profit: The Company recorded a gross profit in Q1 FY2020 of $1,362,271 compared to $71,688 for the same period last year. The overall gross margin percentage on sales decreased by 5% from 80% in Q1 FY2020 to 75% in this financial quarter. This decrease was due to the higher supplier pricing and approximately 5 times higher shipping costs during the lock downs and various restrictions...